AU3779499A - Cloning and expression of recombinant plasmepsins - Google Patents

Cloning and expression of recombinant plasmepsins

Info

Publication number
AU3779499A
AU3779499A AU37794/99A AU3779499A AU3779499A AU 3779499 A AU3779499 A AU 3779499A AU 37794/99 A AU37794/99 A AU 37794/99A AU 3779499 A AU3779499 A AU 3779499A AU 3779499 A AU3779499 A AU 3779499A
Authority
AU
Australia
Prior art keywords
plasmepsins
cloning
recombinant
expression
recombinant plasmepsins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37794/99A
Inventor
John Barton Dame
Charles Adam Yowell Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Florida
Original Assignee
University of Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Florida filed Critical University of Florida
Publication of AU3779499A publication Critical patent/AU3779499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU37794/99A 1998-04-30 1999-04-30 Cloning and expression of recombinant plasmepsins Abandoned AU3779499A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7033798A 1998-04-30 1998-04-30
US09070337 1998-04-30
PCT/US1999/009548 WO1999055848A2 (en) 1998-04-30 1999-04-30 Cloning and expression of recombinant plasmepsins

Publications (1)

Publication Number Publication Date
AU3779499A true AU3779499A (en) 1999-11-16

Family

ID=22094680

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37794/99A Abandoned AU3779499A (en) 1998-04-30 1999-04-30 Cloning and expression of recombinant plasmepsins

Country Status (2)

Country Link
AU (1) AU3779499A (en)
WO (1) WO1999055848A2 (en)

Also Published As

Publication number Publication date
WO1999055848A3 (en) 2000-04-13
WO1999055848A2 (en) 1999-11-04

Similar Documents

Publication Publication Date Title
AU4903600A (en) An insulating construction form and manner of employment for same
AU8140898A (en) Inhibitors of beta-lactamases and uses therefor
AU9128798A (en) Genotyping of human cyp3a4
AU2243497A (en) Laser induced improvement of surfaces
AU3887900A (en) Protamine fragment compositions and methods of use
AU5134599A (en) Expression of functional eukaryotic proteins
AU2259897A (en) Methods and compositions for the simultaneous control of rootdiseases
AU2091799A (en) Uses of alpha-conotoxin peptides
AU2557097A (en) Enhanced expression of transgenes
AU6303898A (en) Component of bromelain
AU5923998A (en) 2-benzoylamino-3-phenylpropenamide derivatives and methods of using the same
AU1287100A (en) Peptide inhibitor of browman-birk type
AU9061798A (en) Protease variants and compositions
AU4257599A (en) Promoter and constructions for expression of recombinant proteins in filamentousfungi
AU6726498A (en) Azeotropic or pseudoazeotropic compositions and use of these compositions
AU2241699A (en) Expression of proteolytically-sensitive peptides
AU4107397A (en) Cloning of full-length human pex cdna
AU5131699A (en) Cryogranulation of activated protein c
AU3779499A (en) Cloning and expression of recombinant plasmepsins
AU8874198A (en) Antisense treatment of pulmonary hypertension
AU2436095A (en) Cloning, expression, and uses of human lactoferrin
AU3513897A (en) Isolation and cloning of the human (harsa-i) gene and uses thereof
AU9061898A (en) Protease variants and compositions
AU1798100A (en) Use of peptide
EP1071754A4 (en) Recombinant secoisolariciresinol dehydrogenase, and methods of use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase